Search results for "Thrombosis"

DOACs more effective, cost-effective than LMWH for cancer-associated thrombosis

A meta-analysis compared the direct oral anticoagulants (DOACs) apixaban, edoxaban, and rivaroxaban to low-molecular-weight heparin (LMWH) and found that apixaban was usually the most cost-effective option, but that finding hinged on the specific drug price.
https://acphospitalist.acponline.org/archives/2023/01/04/doacs-more-effective-cost-effective-than-lmwh-for-cancer-associated-thrombosis.htm
4 Jan 2023